Physician profile

Zhaijun Fan

Family Medicine · South Bend, IN

NPI 1124225578

$639.48

in general payments reported to CMS, 2019-2025

16 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boehringer Ingelheim Pharmaceuticals, INC. $125.17 2020-2021
Bayer Healthcare Pharmaceuticals INC. $82.58 2021-2022
Novo Nordisk INC $67.64 2019-2021
Takeda Pharmaceuticals U.S.A., INC. $64.13 2019-2022
Amarin Pharma, INC. $55.67 2020-2021
Amgen INC. $48.19 2019
Merck Sharp & Dohme LLC $43.40 2019-2021
Sanofi-Aventis U.S. LLC $34.49 2020-2021
Janssen Pharmaceuticals, INC $29.59 2021
Glaxosmithkline, LLC. $13.95 2021
Kowa Pharmaceuticals America, INC. $13.74 2021
Lilly USA, LLC $12.98 2021
Sun Pharmaceutical Industries INC. $12.61 2019
Abbvie INC. $12.04 2022
Dexcom, INC. $11.81 2022
Show all 16 companies
CompanyGeneral paymentsYearsTop products
Genentech USA, INC. $11.49 2020

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Zhaijun Fan

$639.48

in general payments reported 2019-2025

Years
2019-2022
Top company
Boehringer Ingelheim Pharmaceuticals, INC.

https://glasscript.com/doctor/395062/zhaijun-fan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.